Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Discover more about S&P Global’s offerings
Oncolytics Biotech's interim CEO to head company on a permanent basis
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.